About 
Child & Adolescent Psychopharmacology Update

For the helping professional, it is critical to stay up to date on the newest breakthroughs in psychopharmacology treatments for children and adolescents.

But who has time to keep up with hundreds of clinical studies, FDA reports, research, and news--and weed through the hype?

We do.

There is a wealth of information out there about psychotropic medications—not all of it trustworthy. Some is densely written, buried in academic research journals, or biased by their underwriters. There is one publication with the expertise and independence to deliver what you need to care for children and adolescents suffering from psychiatric disorders:

The Brown University Child & Adolescent Psychopharmacology Update

With CPU you’ll stay current with the most successful approaches to treating common childhood disorders. It covers the latest research findings, off-label prescribing practices, case reports, adverse events, and more to keep you informed. And there’s no advertising, so our research is 100% objective and reliable.

This comprehensive coverage cuts through the hype so you can make the best decisions for young people in your care. We wade through the dense studies, distill what really matters, and report the most important details, saving you time and effort.

Stay up to date with CPU and get the latest on:

  • Adverse events such as cardiovascular side effect risks from stimulants
  • New formulations of existing medications that may improve treatment results
  • Case reports that bridge the gap from the lack of large-scale clinical trials on pediatric patients
  • Off-label prescriptions—discover new uses for existing medications
  • Drug interactions—drug combinations that should be avoided
  • FDA news about new regulations, black box warnings, and more

Top 5 Reasons to Subscribe

  1. Learning the latest on psychotropic medication makes my practice more effective
  2. Hearing the latest industry and FDA news keeps me informed
  3. Getting relevant research every month saves me serious time and inconvenience
  4. Reading the latest case reports may improve my outcomes
  5. Keeping up to date on drug interactions - drug combinations that should be avoided

Why Wait?

Get the current newsletter and SUBSCRIBE NOW!

CPU features:

  • BIAS-FREE REPORTING: We do not accept advertising of any kind. Therefore, you can trust our editors and medical writers to deliver the unvarnished truth about psychotropic medications.
  • SPECIALIZED MEDICAL WRITERS AND EDITORS: Unlike the mass media outlets, we have an experienced team who specializes in covering psychotropic medications and mental health. They have the experience to spot the hype and report on what is most significant to your clinical decision making.
  • SUCCINCT YET THOROUGH COVERAGE: We spend the time to wade through the dense studies to distill what really matters. Our editors respect your time, so we report the most important details, but also provide you with our sources if you want to delve more deeply into the topic.
  • Content Directory

    CPU subscribers can now log in to browse all articles online!
    Browse Content
    Free Content
  • Free E-Alerts

    Sign up and get concise news updates on the news covered in Child and Adolescent Psychopharmacology Update—emailed directly to you. It's FREE, so try it today!
    Send
  • Subscription Formats

  • Meet the Editor

    Jeffrey I. Hunt
    Managing Editor

    Jeffrey I. Hunt, M.D. is boarded in adult and child psychiatry and has been a board examiner for the American Board of Psychiatry and Neurology since 1992.
Copyright © 2000-2013 by John Wiley & Sons, Inc. or related companies. All rights reserved.